[go: up one dir, main page]

NO902048L - Stabile opploesninger av rebeccamycinanalog og fremstilling derav. - Google Patents

Stabile opploesninger av rebeccamycinanalog og fremstilling derav.

Info

Publication number
NO902048L
NO902048L NO90902048A NO902048A NO902048L NO 902048 L NO902048 L NO 902048L NO 90902048 A NO90902048 A NO 90902048A NO 902048 A NO902048 A NO 902048A NO 902048 L NO902048 L NO 902048L
Authority
NO
Norway
Prior art keywords
rebeccamycin
acid
stable solutions
preparation
diethylaminoethyl
Prior art date
Application number
NO90902048A
Other languages
English (en)
Other versions
NO176390B (no
NO902048D0 (no
NO176390C (no
Inventor
Ubrani V Venkataram
Miriam K Franchini
Joseph B Bogardus
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO902048D0 publication Critical patent/NO902048D0/no
Publication of NO902048L publication Critical patent/NO902048L/no
Publication of NO176390B publication Critical patent/NO176390B/no
Publication of NO176390C publication Critical patent/NO176390C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
NO902048A 1989-05-10 1990-05-09 Fremgangsmåte for fremstilling av en stabil opplösning av rebeccamycin-analog NO176390C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,608 US5496809A (en) 1989-05-10 1989-05-10 Stable solutions of rebeccamycin analog

Publications (4)

Publication Number Publication Date
NO902048D0 NO902048D0 (no) 1990-05-09
NO902048L true NO902048L (no) 1990-11-12
NO176390B NO176390B (no) 1994-12-19
NO176390C NO176390C (no) 1995-03-29

Family

ID=23373191

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902048A NO176390C (no) 1989-05-10 1990-05-09 Fremgangsmåte for fremstilling av en stabil opplösning av rebeccamycin-analog

Country Status (25)

Country Link
US (1) US5496809A (no)
EP (1) EP0397147B1 (no)
JP (1) JPH0643437B2 (no)
KR (1) KR920004098B1 (no)
CN (1) CN1054510C (no)
AT (1) ATE117313T1 (no)
AU (1) AU618896B2 (no)
CA (1) CA2015632C (no)
CZ (1) CZ283416B6 (no)
DE (1) DE69016087T2 (no)
DK (1) DK0397147T3 (no)
EG (1) EG19218A (no)
ES (1) ES2066902T3 (no)
FI (1) FI95777C (no)
GR (1) GR3015714T3 (no)
HK (1) HK1005033A1 (no)
HU (1) HU206627B (no)
IE (1) IE66515B1 (no)
IL (1) IL94312A (no)
NO (1) NO176390C (no)
PT (1) PT93991B (no)
RU (1) RU2053766C1 (no)
TW (1) TW202390B (no)
YU (1) YU90490A (no)
ZA (1) ZA903535B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69323183T2 (de) * 1992-03-20 1999-05-27 The Wellcome Foundation Ltd., Greenford Weitere indolderivate mit antiviraler wirkung
US5968961A (en) * 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
WO1998019707A1 (en) * 1996-11-05 1998-05-14 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
US20040048012A1 (en) * 1996-11-18 2004-03-11 Weder Donald E. Polymeric materials having a matte finish on a surface thereof
CA2241609C (en) * 1997-06-26 2009-08-25 Southpac Trust International, Inc. Polymeric material having a cloth-like appearance
CN100344285C (zh) * 2005-02-03 2007-10-24 宋艳 多潘立酮水溶性制剂及其制备方法
JP4822151B2 (ja) * 2005-02-14 2011-11-24 山本光学株式会社 眼鏡保持バンドおよびその保持バンド付き眼鏡

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition

Also Published As

Publication number Publication date
CA2015632C (en) 1998-01-27
CZ283416B6 (cs) 1998-04-15
CN1054510C (zh) 2000-07-19
GR3015714T3 (en) 1995-07-31
CZ225590A3 (en) 1997-12-17
DK0397147T3 (da) 1995-03-20
JPH0317094A (ja) 1991-01-25
NO176390B (no) 1994-12-19
IL94312A0 (en) 1991-03-10
EP0397147A2 (en) 1990-11-14
PT93991B (pt) 1996-11-29
FI95777C (fi) 1996-03-25
ZA903535B (en) 1991-01-30
IE901687L (en) 1990-11-10
NO902048D0 (no) 1990-05-09
NO176390C (no) 1995-03-29
PT93991A (pt) 1991-02-08
RU2053766C1 (ru) 1996-02-10
EP0397147A3 (en) 1991-06-12
JPH0643437B2 (ja) 1994-06-08
EP0397147B1 (en) 1995-01-18
AU618896B2 (en) 1992-01-09
DE69016087D1 (de) 1995-03-02
IE66515B1 (en) 1996-01-10
HU206627B (en) 1992-12-28
FI95777B (fi) 1995-12-15
US5496809A (en) 1996-03-05
AU5482390A (en) 1990-11-15
DE69016087T2 (de) 1995-05-24
ATE117313T1 (de) 1995-02-15
HU902989D0 (en) 1990-09-28
HUT54053A (en) 1991-01-28
CA2015632A1 (en) 1990-11-10
KR920004098B1 (ko) 1992-05-25
IL94312A (en) 1994-02-27
HK1005033A1 (en) 1998-12-18
TW202390B (no) 1993-03-21
CN1047204A (zh) 1990-11-28
ES2066902T3 (es) 1995-03-16
KR900017596A (ko) 1990-12-19
YU90490A (en) 1991-10-31
FI902276A0 (fi) 1990-05-07
EG19218A (en) 1994-10-30

Similar Documents

Publication Publication Date Title
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
GT199000066A (es) Suspension farmaceutica acuosa para activos farmaceuticos sustancialmente insolubres en agua
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
FI843286A0 (fi) Stabil, sur vattenloesning av cis-platina laemplig foer injektion.
ES8303086A1 (es) "un metodo para producir una forma de farmaco para administracion no parenteral a base de l-piroglutamil-l-histidil-l-prolinamida."
NO902048D0 (no) Stabile opploesninger av rebeccamycinanalog og fremstilling derav.
DE3863859D1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
FR2681863B1 (fr) Solution de sparfloxacine sa preparation et sel la constituant.
ES2052000T3 (es) Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
DK443988D0 (da) Injektionspraeparat indeholdende modificeret tpa
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
JPS5533446A (en) Amino acid transfusion for postoperative patient

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application